Birth cohort effect on latent tuberculosis infection prevalence, United States

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Winston, Carla A ^a   Navin, Thomas R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BIRTH RATE; BIRTHPLACE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; EPIDEMIOLOGICAL DATA; HEALTH SURVEY; HUMAN; IMMUNOREACTIVITY; INFECTION RATE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; PREVALENCE; UNITED STATES; BIRTH; EPIDEMIOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; COHORT EFFECT; HUMANS; LATENT TUBERCULOSIS; MIDDLE AGED; PARTURITION; PREVALENCE; UNITED STATES;

EID: 77954411023     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-206     Document Type: Article

References (12)

1. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population: The National Health and Nutrition Examination Survey, 1999-2000. Am J Resp Crit Care Med 2008, 177:348-355. 10.1164/rccm.200701-057OC, 17989346.
2. Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Resp Crit Care Med 2008, 177:455-460. 10.1164/rccm.200706-950OC, 18029790.
3. Fitzgerald D, Haas D. Myobacterium tuberculosis. Principles and Practice of Infectious Diseases 2005, 2852-86. Philadelphia, PA, Churchill Livingston, Mandell GL, Bennett JE, and R Dolin, 6.
4. Zevallos M, Justman JE. Tuberculosis in the elderly. Clin Geriatr Med 2003, 19:121-123. 10.1016/S0749-0690(02)00057-5, 12735118.
5. Al Mazrou AM. Booster effect of two-step tuberculin skin testing among hospital employees from areas with a high prevalence of tuberculosis. Infect Control Hosp Epidemiol 2004, 25:1117-1120. 10.1086/502355, 15636304.
6. Snider DE, Cauthen GM. Tuberculin skin testing of hospital employees: infection, "boosting," and two-step testing. Am J Infect Control 1984, 12:305-311. 10.1016/0196-6553(84)90001-4, 6569787.
7. Menzies R, Vissandjee B, Rocher I, St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 1994, 120:190-198.
8. Smith DT. Diagnostic and prognostic significance of the quantitative tuberculin skin tests. Ann Intern Med 1967, 67:919-946.
9. CDC Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000, 49:1-54. RR06, CDC.
10. Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007, 176:306-313. 10.1164/rccm.200702-201OC, 17507546.
11. CDC Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005, 54:49-55. CDC.
12. Frost WH. The age selection of mortality from tuberculosis in successive decades. Am J Hyg 1939, 30:91-96.